Print Friendly, PDF & Email

NCT/Study#

NA /

CP-NEXI-002-01

A Phase 1 / 2 Study To Evaluate The Safety And Tolerability Of Adoptively Transferred Autologous T Cells In Patients With Relapsed Refractory Multiple Myeloma

DISEASE GROUP:
Multiple Myeloma
current phase:
Phase 1/2
STUDY STATUS:
Active
Location:
Hackensack, NJ
For More information: